Radek Jakša
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
Papers in
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
-
- Lymphoma Diagnosis and Treatment 9
- Co-authors
- Pavel DundrMichaela BártůKristýna NěmejcováPavel KlenerIvana TicháPetra VočkováMarek TrněnýOndřej Kodet
- Journals
- Blood (4 papers)Scientific Reports (2 papers)Laboratory Investigation (2 papers)Clinical Cancer Research (1 paper)Pigment Cell & Melanoma Research (1 paper)
- Partner nations
- CzechiaUnited StatesTaiwan
In The Last Decade
Radek Jakša
24 papers receiving 324 citations
Peers
Comparison fields: 5 of 54
- Genetics 64
- Oncology 146
- Pathology and Forensic Medicine 93
- Cancer Research 47
- Hematology 26
Countries citing papers authored by Radek Jakša
This map shows the geographic impact of Radek Jakša's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radek Jakša with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radek Jakša more than expected).
Fields of papers citing papers by Radek Jakša
This network shows the impact of papers produced by Radek Jakša. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radek Jakša. The network helps show where Radek Jakša may publish in the future.
Co-authors
The 25 scholars most cited alongside Radek Jakša, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 36 | |
| 10 | 2019 | 16 | |
| 11 | [Evaluation of inflammatory cells (tumor infiltrating lymphocytes - TIL) in malignant melanoma]. | 2019 | 1 |
| 12 | 2018 | 5 | |
| 13 | 2018 | 10 | |
| 14 | 2017 | 19 | |
| 15 | 2016 | 9 | |
| 16 | 2015 | 72 | |
| 17 | 2014 | 28 | |
| 18 | 2014 | 24 | |
| 19 | 2014 | 7 | |
| 20 | 2012 | 25 |
About Radek Jakša
Radek Jakša is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Immunology and Allergy and Reproductive Medicine, having authored 27 papers that have together received 326 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers), Viral-associated cancers and disorders (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Genetics (64 citations), Oncology (146 citations), Pathology and Forensic Medicine (93 citations), Cancer Research (47 citations) and Hematology (26 citations). Radek Jakša has collaborated with scholars based in Czechia, United States and Taiwan. Frequent co-authors include Pavel Dundr, Michaela Bártů, Kristýna Němejcová, Pavel Klener, Ivana Tichá, Petra Vočková, Marek Trněný, Ondřej Kodet, Romana Michálková and Jan Molinský. Their work appears in journals such as Blood, Scientific Reports, Laboratory Investigation, Clinical Cancer Research and Pigment Cell & Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.